Perrigo Company plc Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
Perrigo Company plc (PRGO) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $1.80 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2026-02-26
- Perrigo Company plc unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2025 was $1.80M, a 83.64% decline from fiscal 2024.
- Perrigo Company plc unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2024 was $11.00M, a 89.51% decline from fiscal 2023.
- Perrigo Company plc unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2023 was $104.90M, a 513.45% increase from fiscal 2022.
- Perrigo Company plc unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2022 was $17.10M, a 59.19% decline from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 6 month | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 6 month as first filed | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month |
|---|---|---|---|
| 2025-12-31 | $1.80M 10-K · filed 2026-02-26 | ||
| 2024-12-31 | $11.00M 10-K · filed 2026-02-26 | ||
| 2023-12-31 | $104.90M 10-K · filed 2025-02-28 | ||
| 2022-12-31 | $17.10M 10-K · filed 2023-02-28 | ||
| 2021-12-31 | $41.90M 10-K · filed 2023-02-28 | ||
| 2020-12-31 | $1.00M 10-K · filed 2022-03-01 | ||
| 2019-12-31 | $12.10M 10-K · filed 2021-03-01 | ||
| 2018-12-31 | $6.40M 10-K · filed 2020-02-27 | ||
| 2017-12-31 | $99.40M 10-K · filed 2019-02-27 | ||
| 2015-12-31 | $43.50M 10-K · filed 2018-03-01 | $38.80M 10-KT · filed 2016-02-25 | |
| 2015-06-27 | $0.00 10-K · filed 2015-08-13 | ||
| 2014-06-28 | $0.00 10-K · filed 2015-08-13 | ||
| 2013-06-29 | $0.00 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |